RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Coverage of IDE Clinical Trial Costs: Navigating the Medicare Maze

Coverage of IDE Clinical Trial Costs: Navigating the Medicare Maze

Posted 01 November 2011 | By Jeffrey D. Zigler, JD

Regulatory professionals recognize the value of clinical research in the medical device development process. The reward of obtaining third-party insurance coverage during a clinical trial is significant, but seeking such coverage by third-party payers has proven complex and confusing even for the most seasoned of professional teams.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe